SCHEMBL10104800

SCHEMBL10104800

COC(=O)CC1CSCC(=O)N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.39
BRD4 O60885 1/20 0.36
TDP1 Q9NUW8 3/20 0.35
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PPARG P37231 2/20 0.33
NR2E3 Q9Y5X4 2/20 0.33
NCOR2 Q9Y618 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ITGB1 P05556 2/20 0.33
ITGA5 P08648 2/20 0.33
MAPT P10636 1/20 0.33
ITGB3 P05106 1/20 0.33
ITGB2 P05107 1/20 0.33
ITGAV P06756 1/20 0.33
ITGA2B P08514 1/20 0.33
ITGB5 P18084 1/20 0.33
ITGAL P20701 1/20 0.33
EGFR P00533 1/20 0.33
KMT2A Q03164 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10968083 0.75 ITGB1 (0.59) GAABRD4TDP1HTTHSD17B10
SCHEMBL9836299 0.75 ITGB1 (0.59) GAABRD4TDP1HTTHSD17B10
SCHEMBL9836292 0.75 ITGB1 (0.59) GAABRD4TDP1HTTHSD17B10
SCHEMBL21565414 0.75 GAA (0.41) GAABRD4HTTHSD17B10ITGB1
SCHEMBL21565344 0.75 GAA (0.41) GAABRD4HTTHSD17B10ITGB1
SCHEMBL21565345 0.75 GAA (0.41) GAABRD4HTTHSD17B10ITGB1
SCHEMBL10101200 0.71 KMT2A (0.53) BRD4KMT2A
SCHEMBL8324925 0.70 HLCS (0.33) L3MBTL1
SCHEMBL25298307 0.70 ITGB1 (0.39) TDP1PPARGNR2E3NCOR2L3MBTL1
SCHEMBL2917816 0.70 BRD4 (0.32) GAABRD4HTTHSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120041194-A1 NITROGEN AND SULFUR-CONTAINING HETROCYCLE DERIVATIVES TRIAD MULTITECH PHARMACEUTICALS, INC. (US) 2012-02-16 US disclosed
US-20110269953-A1 Nitrogen and Sulfur-Containing Heterocycle Derivatives ARMILLI MURTY N 2011-11-03 US disclosed
WO-2010025436-A2 NITROGEN AND SULFUR-CONTAINING HETEROCYCLE DERIVATIVES TRIAD MULTITECH PHARMACEUTICALS, INC. (US) 2010-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041194-A1 NITROGEN AND SULFUR-CONTAINING HETROCYCLE DERIVATIVES HRH4, HNMT, TST GAA 3981/4885BRD4 385/4885TDP1 3232/4885
US-20110269953-A1 Nitrogen and Sulfur-Containing Heterocycle Derivatives TST, HNMT, HRH4 GAA 3420/4885BRD4 93/4885TDP1 2792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.